Compare · APGB vs EBAC
APGB vs EBAC
Side-by-side comparison of Apollo Strategic Growth Capital II (APGB) and European Biotech Acquisition Corp. (EBAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APGB and EBAC operate in Blank Checks (Finance), so they compete in similar markets.
- APGB is the larger of the two at $836.6M, about 5.2x EBAC ($160.7M).
Apollo Strategic Growth Capital II
Apollo Strategic Growth Capital II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as APH I (Sub I), Ltd. and changed its name to Apollo Strategic Growth Capital II in December 2020. Apollo Strategic Growth Capital II was incorporated in 2008 and is based in New York, New York.
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Latest APGB
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G filed by Apollo Strategic Growth Capital II
- SEC Form 15-12G filed by Apollo Strategic Growth Capital II
- SEC Form 25-NSE filed by Apollo Strategic Growth Capital II
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
- Apollo Strategic Growth Capital II filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Per-Share Redemption Price For The Public Shares Will Be ~$10.58
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
Latest EBAC
- SEC Form 15-12G filed by European Biotech Acquisition Corp.
- SEC Form 25-NSE/A filed by European Biotech Acquisition Corp. (Amendment)
- European Biotech Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by European Biotech Acquisition Corp.
- European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form DEFA14A filed by European Biotech Acquisition Corp.
- SEC Form SC 13G filed by European Biotech Acquisition Corp.
- European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form SC 13G filed by European Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by European Biotech Acquisition Corp. (Amendment)